Publisher： Adis International
ISSN： 1173-5503
Source： PharmacoEconomics and Outcomes News, Vol.1, Iss.490, 2005-01, pp. : 10-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Moxifloxacin dominates for CAP
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 539, 2007-01 ,pp. :
Access to resources
Recommend
Moxifloxacin, nonstandardised antibacterials equivalent in CAP
Inpharma, Vol. 1, Iss. 1517, 2005-01 ,pp. :
Moxifloxacin monotherapy on par with combination therapy in CAP
Inpharma, Vol. 1, Iss. 1539, 2006-01 ,pp. :
Moxifloxacin: sequential therapy produces rapid improvements in CAP
Inpharma, Vol. 1, Iss. 1440, 2004-01 ,pp. :
Simvastatin a winner regardless of vascular risk level
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 479, 2005-01 ,pp. :